Clinical Trial of Oral Midazolam in Pediatric Endoscopy

Tabriz University1 site in 1 country50 target enrollmentMarch 2007

ConditionsEndoscopy

InterventionsMidazolam

DrugsMidazolam

Overview

Phase: Phase 4
Intervention: Midazolam
Conditions: Endoscopy
Sponsor: Tabriz University
Enrollment: 50
Locations: 1
Primary Endpoint: efficacy and safety of endoscopy in children with used midazolam
Status: Completed
Last Updated: 18 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of our study was to compare the safety and efficacy of oral midazolam during pediatric endoscopy.

Detailed Description

Although gastrointestinal endoscopy is widely accepted as fundamental to the diagnosis and treatment of digestive disorders in children, considerable controversy and practice differences persist with respect to the methods and agents used to achieve optimal endoscopic sedation. Comparison:oral midazolam vs midazolam IV in sedation and comfort scale of pediatric endoscopy.

Registry

clinicaltrials.gov

Start Date

March 2007

End Date

March 2008

Last Updated

18 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Tabriz University

Eligibility Criteria

Inclusion Criteria

•All of patients scheduled for endoscopy participated in the study.

Exclusion Criteria

•Exclusion criteria were as follows:
•Children younger than 3 years;
•Children with significant neurological disability;
•Children with a history of allergies to benzodiazepines, or to their components;
•Children with metabolic, cardiac or renal disease; children with previous - Complications to IV sedation;
•Children with respiratory distress
•Age under 1 mo and bigger than 17y
•History of erythromycin used in 4 week ago